Skip Nav Destination
results of
Opioid-Use Disorder
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Newsletter
Article Type
Tags
Date
Availability
1-18 of 18 results of
Opioid-Use Disorder
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2020) 25 (1): 3–11.
Published: 01 January 2020
.... This article addresses the question of rating the impairment for an individual with no history of substance use disorder before a work injury, who is prescribed opioids for this injury, and who subsequently develops opioid use disorder (OUD). The Diagnostic and Statistical Manual of Mental Disorders, Fifth...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2021) 26 (5): 3–12.
Published: 01 September 2021
...) Narcotic Opioid Opioid-Use Disorder OUD Independent medical and impairment evaluations often involve a patient who is taking chronic opioids. Therefore, evaluating physicians need to understand the current science pertaining to opioid therapy and how this impacts patients and these assessments...
Newsletter Articles
Joseph A. Hirsch, PhD, PsyD, Steven Mandel, MD, Kurt T. Hegmann, MD, MPH, Alexandra G. Stratyner, PhD, Stuart Gitlow, MD, MPH, MBA, James B. Talmage, MD, Christopher R. Brigham, MD
Newsletter:
Guides Newsletter
Guides Newsletter (2023) 28 (2): 1–38.
Published: 01 March 2023
..., increased opioid-prescribing practices, pharmaceutical marketing, and co-prescriptions of nonopioid drugs used to treat epilepsy and pain disorders. These contributing factors, among others, are discussed below. Patients with comorbid psychiatric disorders demonstrate poorer treatment adherence...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2011) 16 (2): 1–7.
Published: 01 March 2011
... . Psychoneuroendocrinology . 2009 ; 34 Suppl 1 : S162 - S168 . 13. Teichtahl H , Wang D. Sleep-disordered breathing with chronic opioid use . Expert Opin Drug Saf . 2007 ; 6 ( 6 ): 641 - 649 . 14. Wang D , Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2023) 28 (1): 16–30.
Published: 01 January 2023
... nociceptive pain, with a decreased responsiveness to peripherally directed therapies such as anti-inflammatory drugs and opioids, surgery, or injections.” 8 If invasive treatment is being requested for chronic pain, and invasive treatment has the risk of significant potential complications...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2013) 18 (1): 1–18.
Published: 01 January 2013
... . Critical issues on opioids in chronic non-cancer pain: an epidemiological study . Pain. 2006 ; 125 ( 1-2 ): 172 – 179 . Ferrari R , Schrader H , Obelieniene D . Prevalence of temporomandibular disorders associated with whiplash injury in Lithuania . Oral Surg Oral Med Oral Pathol...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2022) 27 (4): 1–17.
Published: 01 July 2022
.... Talmage JB , Snyder RB . Opioids: current science . AMA Guides Newsletter , 2021 ; 26 ( 5 ): 3 – 12 . doi: 10.1001/amaguidesnewsletters.2021.SeptOct01 . In future issues, we will revisit the term spasm regarding spinal impairment rating and treatment, and we will introduce the newly...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2019) 24 (4): 3–14.
Published: 01 July 2019
... of the disorder(s) ▪ If symptoms escalate ▪ If opioid or other medication use continues or increases, especially when exceeding relevant guidelines 66 ▪ If functional status fails to progress ▪ When the claim exceeds the disability duration predicted by available guidelines (To be successful...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2000) 5 (5): 4–5.
Published: 01 September 2000
... to IMEs, identify strengths and weaknesses, and consider what can be done to improve efficiency and quality. © 2000 American Medical Association. All Rights Reserved. 2000 American Medical Association Spinal cord (dorsal column) stimulation (SCS) and intraspinal opioids (ISO) are treatments...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2017) 22 (6): 3–11.
Published: 01 November 2017
... for abusers of alcohol (3.57), cocaine (2.40), opioids (4.26), marijuana (3.73), and methamphetamine (2.58). 61 Patients with substance use disorders had a 25 times greater risk of mortality within the first year after release from a psychiatric facility. 62 Persons with cluster B personality...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2006) 11 (6): 1–3, 8-11.
Published: 01 November 2006
... . Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy . Pain. 2002 ; 100 : 213 – 217 . 21. Glass LS . Occupational Medicine Practice Guidelines, 2nd Ed. Beverly Farms, Mass : American College of Occupational and Environmental Medicine, OEM Press ; 2004...
Newsletter Articles
Christopher R. Brigham, MD, James B. Talmage, MD, Marjorie Eskay-Auerbach, MD, JD, Charles N. Brooks, MD
Newsletter:
Guides Newsletter
Guides Newsletter (2013) 18 (5): 11–12.
Published: 01 September 2013
... consideration of probable behavioral, personality, or other psychosocial issues. Prescription narcotics are a major obstacle to maximum medical improvement, 2 and the ongoing opioid use is likely contributing to his chronic pain. In those on daily analgesics, the most common cause of cephalgia is medication...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2021) 26 (3): 8–13.
Published: 01 May 2021
...-blockers), may be used. Opioids should be avoided. There is no curative therapy, and there is a lack of high-quality evidence for an effective drug regimen. Interventional procedures may be provided independently but are best used to facilitate engagement in functional therapies and to improve quality...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2017) 22 (4): 3–5.
Published: 01 July 2017
... Considering opioid use as acceptable treatment for chronic pain, 9 Accepting examinee-reported history as credible, 10 , 11 Diagnosing complex regional pain syndrome based on subjective complaints, 12 Equating subjective complaints to objective findings, 13 Basing causation...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2007) 12 (5): 1–4, 12-16.
Published: 01 September 2007
... . 2002 ; 44 : 459 – 68 . 46. Mao J : Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy . Pain . 2002 ; 100 : 213 – 217 . 47. American College of Occupational and Environmental Medicine : Pain, suffering, and the restoration of function , in Glass...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2006) 11 (3): 6–8.
Published: 01 May 2006
... loss (excision of the entire disc), a higher rate of complications, 5 and on average inferior results. Because discectomy warrants a Category III rating, it seems logical to rate a one level ADR as Category IV. Blumenthal et al reported 72% of all patients were still using opioid analgesics...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2008) 13 (4): 6–14.
Published: 01 July 2008
... in the Workers Compensation population when compared to the general population. Patients with characterologic traits or disorders may use physical complaints for secondary gain–monetary rewards, avoidance of arrest, solicitation of opioids or benzodiazepines. The concept of secondary gain is difficult...
Newsletter Articles
Newsletter:
Guides Newsletter
Guides Newsletter (2014) 19 (5): 3–12.
Published: 01 September 2014
... not be expected to cause seizure, except perhaps in the context of abrupt withdrawal, particularly in a person who had a tendency to have seizures. Another medication that can potentially increase the risk of a seizure in this patient's case was tramadol, which is a synthetic opioid similar in potency...